School of Nursing, School of Medicine and Public Health, University of Wisconsin, Madison, WI; Department of Pediatrics Racine, School of Medicine and Public Health, University of Wisconsin, Madison, WI.
Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison.
Chest. 2011 Jul;140(1):170-177. doi: 10.1378/chest.10-1504. Epub 2010 Nov 24.
The objective of this study was to examine relationships between pulmonary health and health-related quality of life (HRQOL) in patients with cystic fibrosis (CF) evaluated longitudinally in the Wisconsin Newborn Screening Project.
Patients aged 8 to 18 years (mean ± SD, 13.5 ± 2.8) in early diagnosis (n = 45) and control (n = 50) groups completed Cystic Fibrosis Questionnaires (CFQs) to measure HRQOL at three data points over a 2-year period. Pulmonary health was evaluated concurrently by the Wisconsin chest x-ray scoring system (WCXR) and pulmonary function tests (PFTs).
WCXR showed significant group differences (P ≤ .023), with the early diagnosis group showing more-severe lung disease. When adjusted for group differences in mucoid Pseudomonas aeruginosa status and pancreatic status, however, WCXR differences and PFT data were not significant. Most patients (74%) had FEV(1) values ≥ 80% predicted (within normal range). For patients aged < 14 years, as WCXR scores worsened CFQ respiratory and physical domain scores decreased (both P ≤ .007). FEV(1)/FVC showed a positive relationship with the respiratory and physical domains (both P ≤ .006). WCXR scores for patients aged ≥ 14 years were associated with CFQ weight, respiratory, and health domains (all P ≤ .011). FEV(1) was associated with CFQ weight, respiratory, health, and physical domains (all P ≤ .003). Changes in pulmonary health were not associated with changes in CFQ over time. Significant group differences on the CFQ-Child social functioning domain favored the control group.
To our knowledge, this study is the first to compare pulmonary outcomes with HRQOL indicators assessed by serial, standardized, patient-reported outcome measures for patients with CF identified either through newborn screening or diagnosed by use of traditional methods. This study found no benefits of newborn screening for pulmonary health or HRQOL after controlling for risk factors. Using WCXR and PFT data collectively helped to identify associations between pulmonary health and HRQOL.
本研究旨在探讨囊性纤维化(CF)患者的肺部健康与健康相关生活质量(HRQOL)之间的关系,这些患者是通过威斯康星州新生儿筛查项目进行纵向评估的。
年龄在 8 至 18 岁(平均值±标准差,13.5±2.8)的早期诊断(n=45)和对照组(n=50)患者在 2 年内的 3 个时间点完成囊性纤维化问卷(CFQ),以测量 HRQOL。肺部健康同时通过威斯康星州胸部 X 射线评分系统(WCXR)和肺功能测试(PFT)进行评估。
WCXR 显示出显著的组间差异(P≤.023),早期诊断组显示出更严重的肺部疾病。然而,当调整粘液化脓性铜绿假单胞菌状态和胰腺状态的组间差异时,WCXR 差异和 PFT 数据没有显著差异。大多数患者(74%)的 FEV1 值≥80%预计值(正常范围内)。对于年龄<14 岁的患者,随着 WCXR 评分的恶化,CFQ 呼吸和生理领域的评分下降(均 P≤.007)。FEV1/FVC 与呼吸和生理领域呈正相关(均 P≤.006)。年龄≥14 岁的患者的 WCXR 评分与 CFQ 体重、呼吸和健康领域相关(均 P≤.011)。FEV1 与 CFQ 体重、呼吸、健康和生理领域相关(均 P≤.003)。肺健康的变化与 CFQ 随时间的变化无关。CFQ-儿童社会功能领域的显著组间差异有利于对照组。
据我们所知,这项研究是首次通过连续、标准化、患者报告的结局测量来比较囊性纤维化患者的肺部结局与 HRQOL 指标,这些患者是通过新生儿筛查或传统方法诊断的。在控制了危险因素后,本研究未发现新生儿筛查对肺部健康或 HRQOL 有任何益处。综合使用 WCXR 和 PFT 数据有助于确定肺部健康与 HRQOL 之间的关系。